Neuromyelitis optica: diagnosis, pathogenesis, and treatment.
about
Longitudinally extensive transverse myelitis in neuromyelitis optica: a prospective study of 13 Caucasian patients and literature review.Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.Refining the association of MHC with multiple sclerosis in African Americans.Potential therapeutic benefit of C1-esterase inhibitor in neuromyelitis optica evaluated in vitro and in an experimental rat modelSmall-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica.Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.Seropositive Neuromyelitis Optica imitating an Intramedullary Cervical Spinal Cord Tumor: Case Report and Brief Review of the Literature.Systemic inflammation and the brain: novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration.Brain-reactive antibodies and disease.Microcystic Inner Nuclear Layer Changes and Retinal Nerve Fiber Layer Defects in Eyes with Glaucoma.Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica.A small-molecule screen yields idiotype-specific blockers of neuromyelitis optica immunoglobulin G binding to aquaporin-4.Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody.Therapeutic cleavage of anti-aquaporin-4 autoantibody in neuromyelitis optica by an IgG-selective proteinaseReview of Animal Models of Neuromyelitis Optica.Neuromyelitis optica (NMO)--an autoimmune disease of the central nervous system (CNS).Monitoring neuromyelitis optica activity.Maintenance plasma exchange therapy for steroid-refractory neuromyelitis optica.
P2860
Q30945169-8F4634C8-D5D9-4E86-B48C-6BC5F78BD20BQ33576962-4B03BB15-D5C7-488C-8497-1FBB4F3D11E3Q33980298-48EF697D-361A-46F8-9C0E-F8EFDBFA436DQ34142474-7F172E95-6D28-48BE-A86D-5845F4DB6A47Q34154265-F540AD2E-4594-44E1-8D59-5239BD4D8629Q34376451-6AD2B543-D683-4114-92FC-19DA0DA7BB30Q34390248-9F5218C1-A718-44EE-BE2E-48B65CE1981DQ34463760-D8C974B1-CE5D-4BC3-9AD1-766890CD053AQ35458567-398EA220-9DEE-42D4-B4D1-3325745D1B49Q35661034-76B139A8-0B22-486E-ADF7-CAD91D1278E1Q35857869-9216D7DA-FB70-4412-A4E7-BA2AB33B0A13Q36347678-B6FD2564-BF8A-45BE-9473-1EA0D412E6D8Q36596808-1888FFD5-708F-42B9-9417-35419989C567Q36852554-D2974E52-8A0F-4A68-B93A-0A4DDF23DA2FQ37588030-7E8EE281-316B-444D-B25A-1C2565863CECQ37794273-FFE7D452-652F-4559-AFDC-A8DF251F159BQ38140020-2257EA03-C1DD-4035-8B46-5994C8856344Q47926002-61C748BF-9A6E-4042-AF77-E3257325F24E
P2860
Neuromyelitis optica: diagnosis, pathogenesis, and treatment.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Neuromyelitis optica: diagnosis, pathogenesis, and treatment.
@ast
Neuromyelitis optica: diagnosis, pathogenesis, and treatment.
@en
type
label
Neuromyelitis optica: diagnosis, pathogenesis, and treatment.
@ast
Neuromyelitis optica: diagnosis, pathogenesis, and treatment.
@en
prefLabel
Neuromyelitis optica: diagnosis, pathogenesis, and treatment.
@ast
Neuromyelitis optica: diagnosis, pathogenesis, and treatment.
@en
P2860
P1476
Neuromyelitis optica: diagnosis, pathogenesis, and treatment.
@en
P2093
Bruce Cree
P2860
P2888
P304
P356
10.1007/S11910-008-0066-2
P577
2008-09-01T00:00:00Z
P5875
P6179
1034448983